InvestorsHub Logo

DrBones

10/13/20 6:52 AM

#327909 RE: roiresearch #327908

Yes, Dr. Angela Rasmussen retweeted the Remdesivir combo PR and stated that it looks very promising, but still early on in development. We need that pre-print or a trial start to really ramp up the exposure. She has 172k followers. With another vaccine trial halt, today would be another good day for a therapeutic PR, right Leo!!?!